Another four genes (BAX, MDM2, ZMAT3, and CDKN1A) belonged to the 10 upregulated genes in circulating wild type TP53 leukaemia cells of patients treated with the MDM2-antagonist RG7112 and were absent in mutated TP53 leukaemia cells35. This evidence concerns the gene ZMAT3 and leukemia.